{"id":"https://openalex.org/W7151996367","doi":"https://doi.org/10.1016/j.vaccine.2026.128553","title":"Safety and immunogenicity of a cytomegalovirus (CMV) recombinant glycoprotein B (gB) vaccine in combination with polyacrylate or an emulsion-based adjuvants","display_name":"Safety and immunogenicity of a cytomegalovirus (CMV) recombinant glycoprotein B (gB) vaccine in combination with polyacrylate or an emulsion-based adjuvants","publication_year":2026,"publication_date":"2026-04-01","ids":{"openalex":"https://openalex.org/W7151996367","doi":"https://doi.org/10.1016/j.vaccine.2026.128553","pmid":"https://pubmed.ncbi.nlm.nih.gov/41955926"},"language":"en","primary_location":{"id":"doi:10.1016/j.vaccine.2026.128553","doi":"https://doi.org/10.1016/j.vaccine.2026.128553","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.vaccine.2026.128553","pdf_url":null,"source":{"id":"https://openalex.org/S27359860","display_name":"Vaccine","issn_l":"0264-410X","issn":["0264-410X","1873-2518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071754737","display_name":"Sylvie Pichon","orcid":"https://orcid.org/0009-0001-4612-5621","observed_orcids":["https://orcid.org/0009-0001-4612-5621"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Sylvie Pichon","raw_affiliation_strings":["Global Clinical Development, Sanofi, Campus M\u00e9rieux, Marcy-l'\u00c9toile, France. Electronic address: sylvie.pichon@sanofi.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Clinical Development, Sanofi, Campus M\u00e9rieux, Marcy-l'\u00c9toile, France. Electronic address: sylvie.pichon@sanofi.com","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133235445","display_name":"Isabelle Bruy\u00e8re","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Bruy\u00e8re","raw_affiliation_strings":["Patient Safety & Pharmacovigilance, Sanofi Campus Carteret, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Patient Safety & Pharmacovigilance, Sanofi Campus Carteret, Lyon, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006973436","display_name":"St\u00e9phane Janicot","orcid":"https://orcid.org/0000-0002-6130-5532","observed_orcids":["https://orcid.org/0000-0002-6130-5532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"St\u00e9phane Janicot","raw_affiliation_strings":["SOLADIS, Groupe Efor, Levallois-Perret, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SOLADIS, Groupe Efor, Levallois-Perret, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119346698","display_name":"Widad Silhadi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Widad Silhadi","raw_affiliation_strings":["Patient Safety & Pharmacovigilance, Sanofi Campus Carteret, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Patient Safety & Pharmacovigilance, Sanofi Campus Carteret, Lyon, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047380875","display_name":"Sophie Pallardy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sophie Pallardy","raw_affiliation_strings":["Biostatistical Sciences, Sanofi, Campus M\u00e9rieux, Marcy-l'\u00c9toile, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistical Sciences, Sanofi, Campus M\u00e9rieux, Marcy-l'\u00c9toile, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039656678","display_name":"Ada-Maria Minutello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ada-Maria Minutello","raw_affiliation_strings":["Global Clinical Development, Sanofi, Campus M\u00e9rieux, Marcy-l'\u00c9toile, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Clinical Development, Sanofi, Campus M\u00e9rieux, Marcy-l'\u00c9toile, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072900620","display_name":"Yves Donazzolo","orcid":"https://orcid.org/0009-0002-4314-607X","observed_orcids":["https://orcid.org/0009-0002-4314-607X"]},"institutions":[{"id":"https://openalex.org/I4210155911","display_name":"Eurofins (France)","ror":"https://ror.org/04mdycw91","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210150086","https://openalex.org/I4210155911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yves Donazzolo","raw_affiliation_strings":["Eurofins Optimed, Gieres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eurofins Optimed, Gieres, France","institution_ids":["https://openalex.org/I4210155911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038098039","display_name":"Mathilde Latreille","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155911","display_name":"Eurofins (France)","ror":"https://ror.org/04mdycw91","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210150086","https://openalex.org/I4210155911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mathilde Latreille","raw_affiliation_strings":["Eurofins Optimed, Gieres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eurofins Optimed, Gieres, France","institution_ids":["https://openalex.org/I4210155911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012325649","display_name":"Laurent Bel\u0153il","orcid":"https://orcid.org/0000-0003-3313-602X","observed_orcids":["https://orcid.org/0000-0003-3313-602X"]},"institutions":[{"id":"https://openalex.org/I4210140983","display_name":"BIOASTER","ror":"https://ror.org/04awzyg03","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210140983"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurent Beloeil","raw_affiliation_strings":["Head of Vaccine Program, BioAster, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Head of Vaccine Program, BioAster, Lyon, France","institution_ids":["https://openalex.org/I4210140983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051008333","display_name":"Nathalie Gar\u00e7on","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140983","display_name":"BIOASTER","ror":"https://ror.org/04awzyg03","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210140983"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nathalie Garcon","raw_affiliation_strings":["Chief Scientific Officer, BioAster, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chief Scientific Officer, BioAster, Lyon, France","institution_ids":["https://openalex.org/I4210140983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088135368","display_name":"Anke Pagnon","orcid":"https://orcid.org/0000-0001-9295-3439","observed_orcids":["https://orcid.org/0000-0001-9295-3439"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anke Pagnon","raw_affiliation_strings":["Research and Development, Sanofi, Campus M\u00e9rieux, Marcy l'\u00c9toile, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Sanofi, Campus M\u00e9rieux, Marcy l'\u00c9toile, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024399210","display_name":"Fr\u00e9d\u00e9rique Jantet-Blaudez","orcid":"https://orcid.org/0000-0002-7139-9042","observed_orcids":["https://orcid.org/0000-0002-7139-9042"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fr\u00e9d\u00e9rique Jantet-Blaudez","raw_affiliation_strings":["Research and Development, Sanofi, Campus M\u00e9rieux, Marcy l'\u00c9toile, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Sanofi, Campus M\u00e9rieux, Marcy l'\u00c9toile, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044629255","display_name":"Fabienne Piras-Douce","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabienne Piras-Douce","raw_affiliation_strings":["Research and Development, Sanofi, Campus M\u00e9rieux, Marcy l'\u00c9toile, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Sanofi, Campus M\u00e9rieux, Marcy l'\u00c9toile, France","institution_ids":["https://openalex.org/I3018075036"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5071754737"],"corresponding_institution_ids":["https://openalex.org/I3018075036"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":3.3638,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.85113541,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"80","issue":null,"first_page":"128553","last_page":"128553"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.013100000098347664,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13410","display_name":"Immune responses and vaccinations","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytomegalovirus-vaccine","display_name":"cytomegalovirus vaccine","score":0.9150000214576721},{"id":"https://openalex.org/keywords/glycoprotein-b","display_name":"glycoprotein B","score":0.8700000047683716},{"id":"https://openalex.org/keywords/recombinant-vaccine","display_name":"recombinant vaccine","score":0.7540000081062317},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.8149999976158142},{"id":"https://openalex.org/keywords/reactogenicity","display_name":"reactogenicity","score":0.8790000081062317},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.9390000104904175},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.9179999828338623},{"id":"https://openalex.org/keywords/igg-subclasses","display_name":"IgG subclasses","score":0.9259999990463257},{"id":"https://openalex.org/keywords/memory-b-cells","display_name":"memory B cells","score":0.9300000071525574},{"id":"https://openalex.org/keywords/t-follicular-helper-cells","display_name":"T follicular helper cells","score":0.9039999842643738},{"id":"https://openalex.org/keywords/plasmablasts","display_name":"plasmablasts","score":0.9279999732971191},{"id":"https://openalex.org/keywords/th1-response","display_name":"Th1 response","score":0.6549999713897705},{"id":"https://openalex.org/keywords/vaccine-adjuvants","display_name":"vaccine adjuvants","score":0.5609999895095825},{"id":"https://openalex.org/keywords/first-in-human","display_name":"first-in-human","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.9193999767303467},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7825000286102295},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.616599977016449},{"id":"https://openalex.org/C2777732132","wikidata":"https://www.wikidata.org/wiki/Q6946","display_name":"Cytomegalovirus","level":5,"score":0.5662000179290771},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4722999930381775},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.4544999897480011},{"id":"https://openalex.org/C2779820661","wikidata":"https://www.wikidata.org/wiki/Q6929","display_name":"Human cytomegalovirus","level":3,"score":0.4388999938964844},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.39800000190734863},{"id":"https://openalex.org/C2776409557","wikidata":"https://www.wikidata.org/wiki/Q149348","display_name":"Herpesviridae","level":4,"score":0.3610000014305115},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.3434999883174896},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3188999891281128},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.31450000405311584},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.3018999993801117},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29980000853538513},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2782000005245209},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.2777999937534332},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.2766999900341034},{"id":"https://openalex.org/C39060996","wikidata":"https://www.wikidata.org/wiki/Q7302706","display_name":"Recombinant virus","level":4,"score":0.2759000062942505},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.27549999952316284}],"mesh":[{"descriptor_ui":"D000071497","descriptor_name":"Immunogenicity, Vaccine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000089582","descriptor_name":"Adjuvants, Vaccine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000180","descriptor_name":"Acrylic Resins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003586","descriptor_name":"Cytomegalovirus Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003587","descriptor_name":"Cytomegalovirus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004655","descriptor_name":"Emulsions","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014614","descriptor_name":"Vaccines, Synthetic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014614","descriptor_name":"Vaccines, Synthetic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014614","descriptor_name":"Vaccines, Synthetic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014759","descriptor_name":"Viral Envelope Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D022482","descriptor_name":"Cytomegalovirus Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D022482","descriptor_name":"Cytomegalovirus Vaccines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D022482","descriptor_name":"Cytomegalovirus Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.vaccine.2026.128553","doi":"https://doi.org/10.1016/j.vaccine.2026.128553","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.vaccine.2026.128553","pdf_url":null,"source":{"id":"https://openalex.org/S27359860","display_name":"Vaccine","issn_l":"0264-410X","issn":["0264-410X","1873-2518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"journal-article"},{"id":"pmid:41955926","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41955926","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G3392039740","display_name":null,"funder_award_id":"ANR\u201010\u2010AIRT\u201003","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"}],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320320883","display_name":"Agence Nationale de la Recherche","ror":"https://ror.org/00rbzpz17"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1965145857","https://openalex.org/W1971742580","https://openalex.org/W1982895831","https://openalex.org/W1989525088","https://openalex.org/W2023144510","https://openalex.org/W2029884055","https://openalex.org/W2036060230","https://openalex.org/W2048862104","https://openalex.org/W2061682040","https://openalex.org/W2102235987","https://openalex.org/W2114858538","https://openalex.org/W2170669821","https://openalex.org/W2171944774","https://openalex.org/W2186253039","https://openalex.org/W2304140687","https://openalex.org/W2571781196","https://openalex.org/W2611690321","https://openalex.org/W2742500477","https://openalex.org/W2762408654","https://openalex.org/W2927148996","https://openalex.org/W2975002447","https://openalex.org/W3038969067","https://openalex.org/W3042346054","https://openalex.org/W3110016990","https://openalex.org/W3118402923","https://openalex.org/W3129895460","https://openalex.org/W3144140615","https://openalex.org/W4206509451","https://openalex.org/W4285009689","https://openalex.org/W4321788342","https://openalex.org/W4382632572","https://openalex.org/W4384819234","https://openalex.org/W4388524802"],"related_works":["https://openalex.org/W2166789299","https://openalex.org/W4310842067","https://openalex.org/W2163183562","https://openalex.org/W2133473100","https://openalex.org/W2899681736","https://openalex.org/W7095602956","https://openalex.org/W3137600830","https://openalex.org/W3006671151","https://openalex.org/W2789629714","https://openalex.org/W2132379885"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-04-09T00:00:00"}